Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Klinko Karya Imaji Tbk. (KLIN) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Klinko Karya Imaji Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Klinko Karya Imaji Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Klinko Karya Imaji Tbk. trades at Rp106 (market cap 126.83B, 217.2K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 4.5× Klinko Karya Imaji Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 217.2K). Which is the better fit depends on your goals.

KLINLABS
Market Cap
126.83B576.7B
Volume
217.2K3.48M
Lot
2.17K34.82K
Turnover
21.79M522.79M
Average Price
100.34150.13
Value
21.79M522.79M
Indicative Equilibrium Price
106148
Indicative Equilibrium Volume
34350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KLIN
View details
LABS
View details

About Klinko Karya Imaji Tbk.

PT Klinko Karya Imaji Tbk (the Company) was established on November 4, 2016 based on Notarial Deed No. 3 by Ribka Avie Alreta, S.H., M.Kn. The Company started its commercial operations in 2017.

Read more on KLIN

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS